Association between preablation and postablation neutrophil‐lymphocyte ratio and atrial fibrillation recurrence: A meta‐analysis

Abstract

Atrial fibrillation (AF) recurrence has become common in patients who have undergone catheter ablation. High neutrophil lymphocyte ratios (NLR) have been linked to an increased risk of recurrent AF. The research is, however, not conclusive. This meta‐analysis addressed the value of easily accessible and affordable pre‐ and postablation NLR levels as indicators of AF recurrence in patients who had undergone ablation. We searched PubMed, SCOPUS, and Google Scholar for pertinent studies through May 2023. Using random effects models, the aggregated odds ratio (OR) of pre‐ and post‐NLR and AF recurrence was estimated. Inter‐study heterogeneity was described using I2 statistics and leave‐one‐out sensitivity analysis. A p‐value < .05 was considered statistically significant. The literature search yielded 270 studies, seven of which were included in this meta‐analysis of 1923 patients who experienced AF recurrence after undergoing ablation. There are five retrospective and two prospective studies with a mean follow‐up of 20.5 months. The unadjusted odds ratio (OR) of AF recurrence for preablation NLR was 1.33 (95% CI: 1.04–1.71, p < .01, I2 = 95.49%), while the adjusted OR was 1.45 (95% CI: 0.87–2.43, p < .01, I2 = 95.1%). The unadjusted odds ratio (OR) for postablation NLR was 1.21 (95% CI: 1.09–1.36, p < .01, I2 = 85.9%), and the adjusted odds ratio (OR) was 1.28 (95% CI: 0.93–1.76), demonstrating significant heterogeneity (I2 = 95.32%) with a p‐value < .01. NLR was significantly associated with AF recurrence prediction. To detect AF recurrence, we recommend that clinicians add a simple NLR blood test to their diagnostic modalities.